Fibroblasts might be necessary, too, as treatment of cancer-associated fibroblasts with IL-1β significantly enhanced their ability to inhibit CD8+ T cell function and proliferation [47], which was mediated by upregulation of PD-L1/2. This evidence concerns the gene CD8A and cancer.